|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02157 LEPU BIO
Nominal 
4.235 +0.150 (+3.672%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (12,229) | (196,394) | (250,836) | (480,928) |
| Net Cash from / (used in) Investing Activities | -- | (105,020) | (61,748) | 83,937 | (74,663) |
| Net Cash from / (used in) Financing Activities | -- | 561,942 | 232,084 | (76,695) | 1,031,965 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 444,693 | (26,058) | (243,594) | 476,374 |
| Cash & Cash Equivalents at beginning of period | -- | 401,286 | 426,015 | 669,397 | 155,168 |
| Effect of Foreign Exchange Rate Changes | -- | 7,051 | 1,329 | 212 | 37,855 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 853,030 | 401,286 | 426,015 | 669,397 |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 27,393 |
| %Change | -34.380% |
| EPS / (LPS) | RMB 0.020 |
| NBV Per Share (¥) | RMB 0.783 |